| Patient | Voltaire |
|---|---|
| Date of birth | 1942-11-21 |
| Identifiers | MRN HR-EN002-SYN; SSN (made up) 000-02-5174 |
| Document date | 2026-04-13 |
| Author | Aurelio Bergström-Nwosu, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
An 83-year-old man with three weeks of visible blood in the urine with small clots, a weak stream, and chronic retention (post-void residual 460 mL) with acute kidney injury, now drained by an indwelling catheter. Please evaluate the hematuria with cystoscopy, advise on the retention and the voiding trial, and interpret his PSA. [S]
Urgency: Soon, within one to two weeks; the bladder is drained and he is stable. [S]
Questions for the consultant:
Voltaire is seen at the request of Dr. Delacroix-Mensah, one week after a catheter was placed for chronic retention with gross hematuria. The urine in the bag has cleared from red to light pink, with one small clot four days ago. He has had no fever, flank pain, or catheter blockage. He describes several years of a slowing stream and getting up at night, worse over the past few months, and three weeks of visible blood. He has stopped the diphenhydramine and the phosphate enemas. He has never smoked, has no exposure to aromatic amines, has not had pelvic radiation or cyclophosphamide, has not travelled where schistosomiasis is common, and has no history of bladder stones. He takes no anticoagulant or antiplatelet drug. He is frank that he would not want major surgery if it meant months of recovery. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
6 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Diphenhydramine 25 mg oral capsule, one capsule at night for sleep (over the counter) | One capsule at bedtime | Oral route | 2025-09-01 to 2026-04-06 | stopped | S |
| Tamsulosin 0.4 mg oral capsule, one capsule at bedtime | One capsule 30 minutes after the evening meal | Oral route | 2026-04-06 | active | S |
| Polyethylene glycol 3350, 17 g in a glass of water once daily | 17 g dissolved in water once daily | Oral route | 2024-01-15 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Visible blood in the urine for three weeks with clots, and a weak stream, straining, and frequent small voids, in a man of 83; under evaluation | active | confirmed | R31.0 | S — Synthetic presenting problem echoing his documented urinary complaints and last illness; superseded by the diagnosis at the third chronic-care visit. |
| Chronic urinary retention with overflow (post-void residual 460 mL at intake), worsened by a nightly anticholinergic sleep aid; drained by an indwelling catheter | active | confirmed | R33.8 | S — Synthetic finding echoing the strangury and catheterization documented in his last weeks. |
| Acute kidney injury from bladder outlet obstruction (creatinine 1.68 mg/dL, from 1.1 mg/dL a year earlier) | resolved | confirmed | N17.9 | S — Synthetic finding; it echoes, without asserting, the later encyclopedia term uremia. |
| Benign prostatic hyperplasia with lower urinary tract symptoms: prostate about 78 mL on CT, enlarged, firm, and smooth on examination, PSA 6.4 ng/mL with a PSA density of 0.08; no prostate biopsy, by shared decision | active | confirmed | N40.1 | S — Synthetic diagnosis echoing the very large prostate described at the 1778 autopsy; whether that prostate was malignant is unknown (CLM-0012). |
| Chronic constipation, lifelong by his account, with long use of laxatives and self-given enemas | active | confirmed | K59.09 | S — Synthetic modern problem echoing his documented colic, purges, and enemas; no diagnosis of inflammatory bowel disease is made. |
Vital signs recorded on 2026-04-13; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thin, alert, and quick |
| Abdomen | Soft and non-tender; bladder not palpable with the catheter draining |
| Genitourinary | Normal external genitalia; catheter draining light pink urine; meatus clean |
| Rectal | Prostate enlarged, about 70 to 80 mL, firm and smooth, with no discrete nodule; no fixed pelvic mass felt |
| Cystoscopy | Flexible cystoscopy: trilobar prostatic enlargement with friable surface vessels; a solid, sessile, partly necrotic tumor about 4 cm on the posterior wall extending to the dome, with surrounding white keratinizing plaques; no other lesions; ureteric orifices clear. Catheter replaced |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-04-13 | Hemoglobin [Mass/volume] in Blood | 11.2 | g/dL | 13.2-16.6 g/dL | Low | S |
| 2026-04-13 | Potassium [Moles/volume] in Serum or Plasma | 4.6 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-04-13 | Urea nitrogen [Mass/volume] in Serum or Plasma | 22 | mg/dL | 8-24 mg/dL | Normal | S |
| 2026-04-13 | Creatinine [Mass/volume] in Serum or Plasma | 1.24 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-04-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 58 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
Data reviewed: CT urography two days after intake: 4.2 cm sessile soft-tissue mass of the posterior bladder wall extending to the dome, wall thickened to 1.8 cm with perivesical stranding; no hydronephrosis; upper tracts clear; prostate about 78 mL with a median lobe; no enlarged nodes or bone lesions. Chest CT: clear. Urine culture: no growth. Urine cytology: atypical squamous cells suspicious for malignancy. Creatinine 1.68 mg/dL at intake and 1.24 mg/dL today (eGFR 58); hemoglobin 11.6 then 11.2 g/dL; PSA 6.4 ng/mL; IPSS 22 before the catheter; post-void residual 460 mL. [S]